Evidence map›Paper›PMID 21085545›Full record

ReviewDeutsches Arzteblatt international2010

The origins of colorectal carcinoma: specific nomenclature for different pathways and precursor lesions.

Andrea Tannapfel, Matthias Neid, Daniela Aust, Gustavo Baretton

Open access · greenAbstract readReview
In one paragraph

Review in Deutsches Arzteblatt international, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer.International journal of clinical and experimental pathology · 2015
    Article
  10. Article
  11. Article
  12. Article
  13. Serrated pathway: alternative route to colorectal cancer.World journal of gastroenterology · 2013
    Review
  14. Article
  15. [Serrated precursor lesions].Der Pathologe · 2011
    Review
  16. Review
  17. Terminology is unclear.Deutsches Arzteblatt international · 2011
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Andrea TannapfelInstitut für Pathologie, Ruhr-Universität Bochum, Bürkle-de-la-Camp Platz 1, 44789 Bochum, Germany.
Matthias Neid
Daniela Aust
Gustavo Baretton
Ruhr University Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe widespread application of molecular methods in pathology has yielded steady advances in our understanding of the origins of colorectal carcinoma. Multiple pathways of carcinogenesis have been demonstrated on the molecular level and visualized on the histopathological level. The WHO has accordingly proposed a number of new designations and terms, particularly for precursor lesions, in order to establish a uniform standard for clinical diagnosis. These should be put into practice at once.

methodsIn this article, we explain the concept of intraepithelial neoplasia, which replaces the older concept of dysplasia. Moreover, we use this concept in describing a new mechanism of carcinogenesis for colorectal carcinoma, on the basis of a selective review of the literature. We estimate the frequency of precursor lesions according to the new concept using data from our own patient collective. Finally, we discuss the clinical consequences, which have been addressed in the German S3 guideline for colorectal carcinoma.

resultsThe new type of precursor lesion, called "sessile serrated adenoma" (SSA), accounts for some 7% of all adenomas in our patient collective and is usually found in the right hemicolon. Traditional serrated adenomas (TSA) made up 1% to 3% of our cases and were found mainly in the left hemicolon and rectum.

conclusionOur observations on the frequency and location of serrated adenomas accord with the initial findings published in the international literature. In view of the risk that serrated lesions will progress more rapidly, it is recommended that they should be completely removed, with follow-up at a short interval thereafter (three years according to the German S3 guidelines).

Indexed as

Models, BiologicalAnimalsCell Transformation, NeoplasticColorectal NeoplasmsHumansPrecancerous Conditions

Identifiers

PMID21085545
PMCPMC2982992
OpenAlexW16460171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.